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ABSTRACT
Aim: Pulse oximetry screening of newborn infants increases early detection of critical
congenital heart disease and minimises the risk of circulatory collapse before surgery. This
study provides an update on the implementation of pulse oximetry screening in the Nordic
countries and proposes standardised guidelines.
Methods: A questionnaire exploring pulse oximetry screening, clinical examination routines
and availability of echocardiography was distributed to all 157 delivery units in the Nordic
countries in June 2013.
Results: We received responses from 156 of the 157 delivery units, and 116 (74%) were
using pulse oximetry screening by September 2013. Preductal and postductal screening
were both used in 59 of 116 units (51%), with just postductal screening in 51 of 116
(44%) and just preductal screening alone in 6 of 116 (5%). Screening was performed
before 24 h in 105 of 116 units (91%). The implementation of screening was highest in
Finland (29/30, 97%), Sweden (42/46, 91%) and Norway (43/48, 90%) and lowest in
Denmark (2/24, 8%) and Iceland (0/8 units).
Conclusion: In Sweden, Norway and Finland, the implementation of pulse oximetry
screening is currently the highest in the world and coverage will be close to 100% in 2014.
We propose uniform Nordic guidelines using preductal and postductal screening before
24 h of age.
INTRODUCTION
If newborns with critical congenital heart defects (CCHD)
are left untreated, they will develop circulatory collapse and
die, usually within a few days or weeks after birth. Although
foetal heart screening has the potential to detect a
substantial proportion of such defects, the majority of cases
of CCHD are still left for postnatal diagnosis in large
populations (1–3). Because symptoms and signs may be
subtle or lacking, CCHD may be missed in the routine
clinical examination of newborns (4,5). Subnormal arterial
oxygen saturation, which is present in most cases of CCHD,
is often clinically undetectable (6).
In a Swedish study, 26% of newborns with CCHD were
discharged without a diagnosis (5). A UK study reported
that one-third of infants with potentially life-threatening
cardiac defects were discharged home with the disease
undetected and 5% of them died before receiving a
diagnosis (7). The trend towards earlier discharge after
birth may increase the risk of this happening (5). A recent
U.S. study estimated that 30% of newborns with CCHD had
a late diagnosis and would have benefitted from CCHD
screening (8).
Large prospective, population-based multicentre studies
from Norway (9), Sweden (1), Germany (10), the United
Kingdom (11) and Poland (12) have confirmed the test
accuracy of universal pulse oximetry screening. In 2012, a
large meta-analysis of 13 high-quality studies comprising
nearly 230 000 infants came to the same conclusion (13).
Key notes
 Pulse oximetry screening of newborn infants increases
early detection of critical congenital heart disease and
minimises the risk of circulatory collapse before surgery.
 In Sweden, Norway and Finland, the implementation of
pulse oximetry screening is currently the highest in the
world and coverage will be close to 100% in 2014.
 We propose uniform Nordic guidelines using preductal
and postductal screening before 24 h of age.
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The most recent contribution to the evidence is also the
largest. A Chinese multicentre study screened 122 738
newborns, confirming the significant improvement in the
detection of CCHD by adding pulse oximetry screening and
proving that this also works in a developing country (14).
In the United States, the Secretary of Health and Human
Services recommended pulse oximetry screening of all
newborns in 2011 (15). The strategy for implementing
screening, endorsed by the American College of Cardiology
Foundation, the American Heart Association and the
American Academy of Paediatrics, was that screening
should be:
1 performed using motion-tolerant oximeters cleared
by the Food and Drug Administration for reporting
functional oxygen saturation;
2 based on the Swedish screening algorithm (1) and
performed by qualified personnel educated in the use
of the algorithm and trained in pulse oximetry
monitoring of newborns (16); and
3 performed between 24 and 48 h of age or shortly
before discharge if <24 h of age.
To stress the importance of using proper equipment for
screening, the recommendation states the use of a pulse
oximeter that can read through motion and low perfusion.
There are currently only four U.S. States that have not yet
taken any action to implement screening. A paper address-
ing the challenges and opportunities of the implementation
process in the United States was published in 2013 (17).
In the United Kingdom, a shift in opinion has been noted
since 2010 and the vast majority of neonatologists are now
in favour of screening (18).
Only four European countries (Switzerland, Ireland,
Poland and Norway) have a national recommendation to
screen despite the fact that all but one of the largest
published multicentre studies were conducted in Europe
(1,9–12).
Recently, at a meeting in Turin, steps were taken by an
international group of neonatologists, paediatric cardiolo-
gists and screening experts to promote CCHD screening
across Europe (19).
The purpose of this study was to examine the extent of
pulse oximetry screening in the Nordic countries, as well as
details of the screening methods used, and to discuss
whether the results could provide a basis for uniform
Nordic guidelines.
PATIENTS AND METHODS
A form containing 28 questions exploring pulse oximetry
screening, clinical examination routines and availability of
echocardiography was distributed to all 157 delivery units
in the Nordic countries in June 2013. The results were
presented at the Nordic Paediatric Cardiology meeting in
Copenhagen in September 2013 and describe the situation
at that point in time. Following this, a proposal for uniform
Nordic guidelines was agreed by the authors.
Descriptive statistics are presented as numbers and
percentages. No statistical comparisons were made.
RESULTS
We received responses to the questionnaire from 156 of the
157 delivery units (Table 1). The number of delivery units
and live births, routines for clinical examination of new-
borns and access to echocardiography in each country are
shown in Table 1. It can be seen that Sweden, Finland and
Denmark have a centralised birth pattern, while in Nor-
way, births are more decentralised. In Iceland, 73% of the
4500 deliveries per year are centralised to Reykjavik, but
the remaining deliveries are distributed between seven
units.
In all Nordic countries, with the notable exception of
Denmark, newborns are routinely examined, at least once,
by a physician before discharge. In Sweden and Finland, the
newborn examination is always performed by a paediatric
consultant or resident, whereas in some units in Norway
and Iceland, nonpaediatric physicians undertake this clin-
ical screening. In Denmark, the physical examination of
newborns by a physician was cancelled in most units in
2007, because it was considered that there was not enough
scientific evidence of its benefits (20). Instead, newborns
are examined by a midwife in 75% of units. Auscultation of
the heart and palpation of femoral pulses, however, are not
part of this examination.
Urgent echocardiography 24 h a day is available for all
newborns in the Nordic countries, but sometimes only after
transport. This is especially so in Norway, where 25 of the
48 delivery units have to transport a baby to another
hospital for echocardiography (Table 1).
Local guidelines regarding investigation of cardiac
malformations in newborns are in use in 85% of all
delivery units in Sweden, 77% in Norway, 87% in Finland
and 76% in Denmark. In Iceland, there are no written
guidelines.
Pulse oximetry screening
In total, 116 of the 156 (74%) responding delivery units
have implemented pulse oximetry screening for CCHD
(Table 1). The implementation of screening is highest in
Finland, Sweden and Norway and lowest in Denmark and
Iceland (Table 1).
There were no national guidelines for pulse oximetry
screening in any of the Nordic countries when the
questionnaire was distributed (June 2013). However,
during that month, the Norwegian Directorate of Health
endorsed universal pulse oximetry screening (21). Regard-
less of the lack of guidelines, screening was gradually
implemented in Sweden, Norway and Finland from 2004.
A high prenatal detection rate was cited as the main
reason for not screening in Denmark and a high prenatal
detection rate combined with a very low neonatal
mortality rate in Iceland. This was the lowest in Europe
for 3 years in a row at 0.9–1.1 per 1000 in 2010–2012.
Other reasons mentioned by units for not screening were
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lack of national guidelines and concerns about false
positives.
Table 1 shows data for pulse oximetry screening routines.
In Sweden, all units use the Granelli protocol, which calls
for preductal and postductal screening (1), whereas in
Norway, most units use only postductal screening (9). In
Finland, there is a mixture of both protocols. The majority
of units in all three countries screen before 24 h of age and
most use motion-tolerant oximeters. In both Sweden and
Norway, 95% of the screening units use reusable sensors in
contrast to Finland, where 55% use disposable sensors. A
mix of midwives and nurses perform the screening, with
midwives making up the majority.
The result of screening is stored electronically in all
Swedish units (17% also keep paper records), 88% in
Norway (17% paper records) and 80% in Finland (12%
paper records). However, none of the units in the Nordic
countries store the results in a digital database enabling
retrieval of data for research purposes, without having to
check each individual patient file.
Uniform guidelines
We propose uniform Nordic guidelines (Table 2) based on
the Swedish algorithm with the modification to always
screen within 24 h of birth. This algorithm is presented in
Figure 1.
DISCUSSION
In this update on pulse oximetry screening routines in the
five Nordic countries, we found that screening had been
successfully implemented in three of them (Sweden, Nor-
way and Finland). This has occurred as a bottom-up
approach, in the absence of national recommendations,
Table 1 Number of delivery hospitals and live births, newborn examination routines, access to echocardiography and pulse oximetry screening routines in the Nordic countries in
September 2013. Percentages were calculated based on the number of responding units unless otherwise stated
Sweden Norway Finland Denmark Iceland Total
Number of delivery units 46 48 30 25 8 157
Number of responding units 46 48 30 24 8 156
Live births 2012 113 137 61 149 59 038 59 527a 4 450 297 301
Number of units with
<500 deliveries 2 (4.3%) 24 (50.0%) 5 (16.7%) 2 (8.3%) 7 (87.5%) 40 (25.6%)
500–1500 12 (26.1%) 11 (22.9%) 11 (36.7%) 6 (25.0%) 0 40 (25.6%)
>1500 32 (69.6%) 13 (27.1%) 14 (46.7%) 16 (66.7%) 1 (12.5%) 76 (48.7%)
Number of examinations by physicianb
0 0 0 0 24 (100.0%) 0 24 (15.4%)
1 37 (80.4%) 43 (89.6%) 26 (86.7%) 0 0 106 (67.9%)
2 9 (19.6%) 5 (10.4%) 4 (13.3%) 0 8 (100.0%) 26 (16.7%)
Transport always needed for echo 4 (8.7%) 25 (52.1%) 5 (16.7%) 16 (66.7%) 6 (75.0%) 56 (35.9%)
Pulse oximetry screening status
Screening by September 2013 42 (91.3%) 43 (89.6%) 29 (96.7%) 2 (8.3%) 0 116 (74.4%)
Will start during 2013 4 (8.7%) 3 (6.3%) 0 0 0 7 (4.5%)
Will start during 2014 0 2 (4.2%) 1 (3.3%) 2 (8.3%) 0 5 (3.2%)
Proportion of neonates screenedc 95% 89% 99% ﬃ10% 0 ﬃ 76%
Units screening at <24 hd 32 (76.2%) 42 (97.7%) 29 (100.0%) 2 (100.0%) – 105 (90.5%)
Screening methodd
Measuring in right hand and
one foot
42 (100.0%) 7 (16.3%) 10 (34.5%) 0 – 59 (50.9%)
Measuring in right hand only 0 5 (11.6%) 1 (3.4%) 0 – 6 (5.2%)
Measuring in one foot only 0 31 (72.1%) 18 (62.1%) 2 (100.0%) – 51 (44.0%)
a2011.
bSecond examination before discharge or at follow-up.
cEstimated based on birth rates 2012 (2011 for Denmark) and screening policy in September 2013.
dPercentages were calculated based on number of units screening by September 2013.
Table 2 The proposed uniform Nordic pulse oximetry screening guidelines
Screening should be done with a motion-tolerant pulse oximeter reading
through low perfusion and reporting functional oxygen saturation
Screening should be based on the endorsed screening algorithm and
performed by qualified personnel who have been educated in the use
of the algorithm and trained in pulse oximetry monitoring of newborns
A positive screen occurs when
One oxygen saturation value is <90%
Oxygen saturation is <95% in both right hand and one foot or there is
a >3% absolute difference in oxygen saturation between the right hand
and one foot on three repeated measurements. Any measurement that
is >95% in either extremity with <3% absolute difference in oxygen
saturation between the upper and lower extremity would be considered
a pass and screening would end
The screening should be conducted within the first 24 h of life
Standards should be developed for digital reporting of the screening result
that can be retrieved for follow-up
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special funding or training. Screening has reached over 90%
coverage across these three countries, currently the greatest
proportion in the world. This shows the feasibility of the
method and clearly dismisses concerns that this method
only works in large research settings with dedicated staff
and funding (22).
In Denmark, the general belief has been that prenatal
detection rates are so high that screening would not be
cost-effective, although actual detection rates have not
been widely acknowledged. In Iceland, an active decision
was made not to screen on the same grounds. We did not
examine prenatal detection rates. However, all five coun-
tries have programmes for foetal heart screening in the
second trimester. These programmes always include the
four-chamber view and in a majority of units also outflow
views and the three-vessel view. The effectiveness of
prenatal screening programmes is, however, highly vari-
able within countries as well as between countries
(2,23,24). Some areas in Sweden, for example, report
more than 75% prenatal detection of CCHD, whereas
other areas detect <25% (personal communications,
unpublished data). The situation in the United Kingdom
is similar, with a wide variation in detection rates (3). In
Denmark, the general assumption has been that the
prenatal detection rate is high, but at the annual Danish
neonatology meeting in 2011, it was reported that the
prenatal detection of CCHD was 34% in 2008–2009 (25).
Partly as a result of the present study, at least two Danish
units are now planning to start pulse oximetry screening,
with a bottom-up approach, while waiting for a national
recommendation.
When employing pulse oximetry screening on national
levels, the diagnostic yield may be lower in areas served by
large university hospitals with effective prenatal screening
programmes compared to other areas, but screening should
be promoted on all levels to optimise the diagnostic yield on
a national level. We encourage a combined approach with
effective prenatal screening according to International
Society of Ultrasound in Obstetrics and Gynaecology
guidelines (26) and postnatal pulse oximetry screening
Pulse Oximetry Screening 
-in the right hand and one foot 
-within 24h of age OR before discharge 
-with a motion tolerant pulse oximeter (16,28) 
<90% 
in right hand or foot 
<95% in right hand AND foot 
OR 
Hand/foot difference >+3% 
 
>95% in right hand and/or foot 
AND 
Hand/foot difference <3% 
 
<90% 
in right hand or foot 
<90% 
in right hand or foot 
<95% in right hand AND foot 
OR 
Hand/foot difference >+3% 
 
<95% in right hand AND foot 
OR 
Hand/foot difference >+3% 
 
Repeat screening after 30min 
-under optimal conditions 
-avoid measuring in deep sleep 
>95% in right hand and/or foot 
AND 
Hand/foot difference <3% 
 
>95% in right hand and/or foot 
AND 
Hand/foot difference <3% 
Inform Physician! 
Screening Positive 
 Screening Negative 
Repeat screening after 30min 
-under optimal conditions 
-avoid measuring in deep sleep 
Figure 1 Proposed screening algorithm for the Nordic countries.
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using the algorithm presented here to optimise perinatal
care of foetuses and newborns with CCHD.
Differences between recommended screening algorithms
One of the main obstacles preventing or delaying imple-
mentation of pulse oximetry screening, reported by physi-
cians in the United Kingdom and the Nordic countries, has
been a lack of national recommendations and/or guide-
lines. When the Norwegian Directorate of Health
endorsed universal pulse oximetry screening in June 2013
(21), it recommended postductal screening after 24 h of
age, thus diverging both from the United States (preductal
and postductal, 24–48 h of age) and our proposal for
common Nordic recommendations (preductal and post-
ductal before 24 h). We believe screening within the first
24 h after birth is justified despite a higher proportion of
false positives (11), because the majority of the false
positives resulting from pulse oximetry screening have true
hypoxia requiring special or intensive care (early infec-
tions, pulmonary hypertension and other pulmonary dis-
orders), and thus can be considered as secondary targets
and an additional advantage with screening (1,9,11,12,14).
In a recent study, Singh et al. (27) evaluated the impact of
CCHD screening before 24 h of age and found that of 208
(0.8%) who screened positive, 17 had CHD and 148 had
other clinical conditions requiring further intervention,
confirming the additional benefit of screening confirming
this additional benefit of screening. In a hypothetical
future situation, with close to 100% prenatal detection rate
of CCHD across all delivery units in a country, including
small delivery units in decentralised organisations, such as
in Norway, there may still therefore be a place for
postnatal pulse oximetry screening. Another justification
for this recommendation is that the screening is already
performed within 24 h in nearly all units in Sweden,
Norway and Finland. Screening may take place either in
the delivery unit before discharge if very early discharge is
planned or before transfer to the nursery, or in the nursery
before 24 h of age.
The recommendation to screen both preductally and
postductally is based on the fact that this increases the
chances of detecting some types of CCHD. In transposition
of the great arteries, with or without aortic arch obstruction,
only postductal screening may miss the hypoxia as these
babies can have a higher, and sometimes normal, postductal
saturation with concomitant critically low preductal satu-
ration (28). Newborns with coarctation of the aorta some-
times have a lower postductal than preductal saturation and
will then be detected by screening if it is performed in both
the right hand and a foot (28). However, most newborns
with coarctation of the aorta have normal saturations both
pre- and postductally and will therefore be missed by pulse
oximetry screening (1). The reason for this is presumably a
large left-to-right shunt across the foramen ovale of fully
saturated blood and a large pulmonary blood flow resulting
in a normal or near-normal saturation in the blood shunted
right to left across the ductus arteriosus. Another mecha-
nism could be that in some neonates, the coarctation may
be mild initially, when pulse oximetry screening is per-
formed, with a pure left-to-right shunt through the ductus
arteriosus. This is an important limitation of the method as
coarctation of the aorta is the CCHD most commonly
overlooked in the newborn examination (5). Careful exam-
ination of the newborn, including palpation of the femoral
pulses and echocardiography before discharge in all neo-
nates with weak or absent femoral pulses, should therefore
be mandatory also in units employing pulse oximetry
screening.
To improve quality in screening for CCHD, the use of a
computer-based tool to interpret the algorithm was
recently proposed (29). The authors found the manual
algorithm to be susceptible to human error. Their findings
underline the importance of proper training of the
personnel to understand the algorithm for CCHD screen-
ing and to make correct interpretations of their measure-
ments.
Limitations
One limitation of this study was that we lacked up-to-date
data on prenatal detection rates for duct-dependent cardiac
defects in all areas of all Nordic countries. Such data would
have been of value to analyse the role of postnatal pulse
oximetry screening routines and recommendations in the
complete perspective of pre- and postnatal detection of
CCHD.
Another limitation was that none of the Nordic countries
employing pulse oximetry screening store the screening
results in a way that data can be retrieved for whole
populations. When such data are available for all newborns,
together with data on whether there was a prenatal
diagnosis or not, a detailed analysis of the relative contri-
butions of the two screening methods on a national level
will be possible.
Challenges for the future
Coarctation of the aorta is the duct-dependent cardiac
defect most often missed on clinical examination of the
newborn, as well as by pulse oximetry screening. Coarcta-
tion is also often overlooked in prenatal ultrasound
screening programmes (3). It is therefore an important
research objective to try to improve pre- and postnatal
detection of coarctation. There is some promise that the
additional use of perfusion index may improve the detection
of aortic arch obstructions after birth (30).
It is hoped that a consensus can be reached by the
respective organisations in the Nordic countries to endorse
uniform guidelines for pulse oximetry screening based on
our proposal. An important next step will be to stimulate
also other countries to consider national recommendations
for pulse oximetry screening of all newborns.
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